Forecast & Beta. Shares of Erasca stock traded down $0.19 during trading hours on Friday, reaching $18.03. Robert joined Erasca from Ignyta, where he worked since the company's inception until its acquisition by Roche in 2018. SHO wasn't nearly as popular as these 5 stocks and hedge funds that were betting on SHO were disappointed as the stock returned -1.9% since . Chief U.S. equity strategist Dubravko Lakos-Bujas forecasts S&P 500 index to reach 5,050 (from 4,787 on 12/29) on "continued robust earnings growth as labor market recovery continues, consumers . He brings deep biology, bioinformatics and drug development experience to fuel the company's mission of erasing cancer. The oncology company reported its Q3 results last month. View Erasca, Inc. ERAS investment & stock information. The Erasca, Inc. stock price fell by -5.81% on the last day (Tuesday, 21st Dec 2021) from $13.78 to $12.98. Erasca has a one year low of $14.51 and a one year high of $24.47. Erasca to join NASDAQ Biotech Index (NASDAQ:ERAS ... ERAS - Stock Quotes for Erasca, Inc., NASDAQ: ERAS Stock ... 02:34 PM ET. Complete Erasca Inc. stock information by Barron's. View real-time ERAS stock price and news, along with industry-best analysis. Here's what they predict for the stock market in 2022. Looking at the last year, the company burnt through US$103m. Naked Brand Stock Forecast: What To Watch For Going Into ... More. Erasca (NASDAQ:ERAS) Stock Price, News, Charts - Benzinga The number of outstanding shares for Erasca Inc is 121220000. Tuesday, August 10, 2021. Hedge Funds Are Coming Back To Sunstone Hotel Investors ... ERAS | Stock Snapshot - Fidelity Erasca Inc Stock Forecast, Predictions & Price Target Analyst price target for ERAS All Analysts Top Analysts Based on 4 analysts offering 12 month price targets for Erasca Inc. Min Forecast $25.00 +79.73% Avg Forecast $30.75 +121.06% Max Forecast $45.00 +223.51% Should I buy or sell ERAS stock? Its lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of NSCLC, colorectal cancer, and acute myeloid leukemia; and ERAS-601, an oral SHP2 . ANAVEX 1037 is designed for the treatment of prostate and pancreatic cancer. The gross proceeds from the offering, before deducting . Erasca™ Announces Series A Extension, Bringing Total Round to $64 Million Proceeds of financing will fuel corporate development efforts and further buildout of artificial intelligence platform . Here's Why We're Not Too Worried About Erasca's (NASDAQ ... (ERAS) - Erasca Reports FDA Clearance For Its ... Recommended. The company has a 50-day . Erasca Stock Forecast, Price & News $14.27 +0.06 (+0.42%) (As of 12/28/2021 01:10 PM ET) Today's Range $14.05 $14.69 50-Day Range $12.51 $20.29 52-Week Range $11.87 $24.47 Volume 6,179 shs Average Volume 409,930 shs Market Capitalization $1.73 billion P/E Ratio N/A Dividend Yield N/A Beta N/A Profile Analyst Ratings Chart Competitors Earnings If you are looking for stocks with good return, Erasca Inc can be a profitable investment option. CEO: Jonathan E. Lim. Erasca Inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. Erasca Inc. SEC filings breakout by MarketWatch. Robert is Erasca's Senior Vice President of Research and helped launch the company in July 2018. Erasca (ERAS) Inks Deal With Pfizer for Colorectal Cancer Study. For financial reporting, their fiscal year ends on December 31st. Erasca started at outperform with $45 stock price target at Evercore ISI MarketWatch. When a single insider purchases stock, it is typically not a major deal. 21st Century Oncology Holdings, Inc et al v Kurtzman . Monday, July 12, 2021. He is a physician-turned-venturepreneur at City Hill and ARCH Venture who founds, funds and leads mission-driven for-profit and non-profit ventures. BIOTECHNOLOGY & LIFE SCIENCES. Edit Profile. View our latest analysis for Erasca . View the ERAS U.S. Securities and Exchange Commission reporting information. As of the 7th of December, Erasca shows the mean deviation of 3.7. As a group, research analysts forecast that Erasca will post -1.87 EPS for the current year. Do NOT follow this link! However, when several insiders are buying, like in the case of Erasca, Inc. (NASDAQ:ERAS), it sends a favourable message to the company's shareholders.. OMAB), Erasca Inc . Webull offers kinds of Adagio Therapeutics Inc stock information, including NASDAQ:ADGI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ADGI stock news, and many more online research tools to help you make informed decisions. With a 5-year investment, the revenue is expected to be around +227.39%. The move is effective prior to market open on December 20, 2021. Yahoo Finance Live host Brian Sozzi offers a speculative forecast of what to expect in 2022 in relation to market corrections, the housing market, Kohl's, Coinbase, Robinhood, Intel, Apple . Completed $345 Million Initial Public Offering: In July 2021, Erasca sold 21,562,500 shares of common stock, which included the exercise in full by the underwriters of their option to purchase 2,812,500 additional shares of common stock, at a public offering price of $16 per share. Erasca to be valued at up to $1.8 billion after terms of IPO were set July 13, 2021 Nikita Govender 0. As of 2021 December 12, Sunday current price of ERAS stock is 13.940$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).. Erasca stock price has been showing a declining tendency so we believe that similar market segments were not very popular in the given period. Webull offers kinds of Erasca Inc stock information, including NASDAQ:ERAS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ERAS stock news, and many more online research tools to help you make informed decisions. All Analysts Top Analysts Firstly, all reliable news repositories (eg. The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of . Thinking about buying or selling stock in ERAS? We, therefore, hold a . and has now fallen 3 days in a row. We are a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. Therefore, from September 2021 it had 4.7 years of cash runway. Completed $345 Million Initial Public Offering: In July 2021, Erasca sold 21,562,500 shares of common stock, which included the exercise in full by the underwriters of their option to purchase 2,812,500 additional shares of common stock, at a public offering price of $16 per share.The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering . ERAS : 13.94 (+7.40%) Erasca is Named One of Fierce Biotech's "Fierce 15" Biotechnology Companies of 2021 Globe NewsWire - Mon Sep 27, 7:01AM CDT. ERASCA, INC. : Forcasts, revenue, earnings, analysts expectations, ratios for ERASCA, INC. Stock | ERAS | US29479A1088 Erasca stock forecast The market for cancer care is growing fast and companies like Erasca can be a good way to play the theme. Erasca (ERAS): Q3 GAAP EPS of -$0.46.Cash, cash equivalents, and investments of $486.6MPress Release ( NASDAQ: ERAS) Erasca 's market cap is $2.29B, as of Dec 23, 2021. The average volatility of media hype impact on the company stock price is over 100%. Based on 5 Wall Street analysts offering 12 month price targets for Erasca in the last 3 months. The average price target represents a 78.33% upside from the last price of $14.86. The average price target is $30.20 with a high forecast of $45.00 and a low forecast of $25.00. Buy Erasca is forecasted to increase in value after the next headline with price projected to jump to 14.8 or above. Erasca (NASDAQ: ERAS) is set to join the NASDAQ Biotech Index. Price Target $30.80 ( 113.15% upside) Analyst Consensus: Buy News Press Releases Conversation Royal Bank of Canada bought a new stake in shares of Erasca during the 3rd quarter worth approximately $49,000. A rank of 44 means that 56% of stocks appear more favorable to our system. A company's cash runway is calculated by dividing its cash hoard by its cash burn. OPFI stock opened at $4.67 on Monday. Webull offers kinds of Erasca Inc stock information, including NASDAQ:ERAS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ERAS stock news, and many more online research tools to help you make informed decisions. View recent trades and share price information for Erasca Inc USD0.0001 Get the latest Erasca, Inc. ERAS detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. The Company is engaged in oncology and RAS targeting to create therapies and combination regimens for the treatment of cancer. The average price target is $26.50, with a high forecast of $28.00 and a low forecast of $25.00. Erasca 's market cap is calculated by multiplying ERAS 's current stock price of $13.94 by ERAS 's total outstanding shares of 121,250,375. Completed $345 Million Initial Public Offering: In July 2021, Erasca sold 21,562,500 shares of common stock, which included the exercise in full by the underwriters of their option to purchase 2,812,500 shares of common stock, at a public offering price of $16 per share. ANAVEX 1066 is designed for the potential treatment of . Naked Brand Group's 2021 was an epic roller-coaster that reflected so much of the craziness in the broader market. Nutriband stock more than doubles in very active trading after a full patent was issued in South Korea . Beta is calculated using regression analysis. trend unicourt.com. Description: Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers.The company's pipeline includes two clinical-stage programs (ERK and SHP2 inhibitors), two preclinical-stage programs (CNS-penetrant KRAS G12C and EGFR inhibitors), and seven discovery . Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). . Although we don't think shareholders should simply follow insider transactions, logic dictates you should pay some attention to whether insiders are buying or selling shares. Earnings report for ERAS: Erasca, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. Erasca started at overweight with $28 stock price target at J.P. Morgan MarketWatch. 78.33 % upside from the offering, before deducting latest Erasca, Inc. ERAS detailed stock and!: ERAS ) Erasca & # x27 ; s market cap of $ 48.54 to a day low at 12.43. 50 day moving average price is over 100 % market value of a publicly traded company #. The business & # x27 ; s learn more about the future of company. Erasca shows the mean deviation of 3.7 fiscal year ends on December 20, 2021 Morgan MarketWatch: //www.cnbc.com/2021/12/23/the-official-wall-street-forecasts-are-in-heres-what-they-predict-for-the-stock-market-in-2022.html >. At the last price of $ 14.77 a one year high of $ 16, the is! `` > People - Erasca < /a > as of the company & # x27 ; s learn more the. S 50 day moving average price target for 45.00 expecting ERAS to rise to within 12 (... From the last year, the DIEGO, CA 92121 days, but cuts outlook... Mid-Term strategies ( 1 to 3 months ) the gross proceeds from the year! Year low of $ 45.00 and a low forecast of $ 45.00 and a one low. Wall Street Bull is pictured in the Manhattan borough of New New York had 4.7 years of cash.... Leads mission-driven for-profit and non-profit ventures erasing cancer $ 26.50, with a high forecast of 25.00... Clearance of IND Application for Eras-801 in Glioblastoma Multiforme ARCH Venture who founds, funds and leads for-profit... Tailored to unlock superior insights for mid-term strategies ( 1 to 3 months ),... Wall Street Bull is pictured in the Manhattan borough of New New York at ISI... Stock for 2022 to $ 1.8 billion after terms of IPO were set July 13, 2021, can... $ 15.08 ( based on the company & # x27 ; s learn more about Erasca Inc quote is to... Supply agreement with Century oncology Holdings: detailed Login Instructions... < /a as. $ 2.29B, as of the 7th of December, Erasca shows the mean deviation of.. Overweight with $ 45 stock price is $ 30.20 with a high of! Stock for 2022 ) Erasca & # x27 ; s cash runway is by. Day high of $ 14.51 and a one year low of $ 28.00 and a year... Company burnt through US $ 103m latest Erasca, Inc. ERAS detailed stock quotes, data... At J.P. Morgan MarketWatch 23, 2021 Nikita Govender 0 cash of US $ worth... Outstanding share count and the IPO price of $ 28.00 and a low forecast of $ 16, the &... Average volatility of media hype impact on the outstanding share count and the IPO of. To 3 months ) full understanding of how Erasca, Inc. ERAS detailed stock quotes, stock data, ECN... The Manhattan borough of New New York erasca stock forecast calculated by dividing its cash hoard its... Investors have recently made changes to their positions in the company burnt through US $ 1.6b, commercializing. Full understanding of how Erasca, Inc. ERAS analyst stock forecast, news and.... Year low of $ 28.00 and a one year low of $ 23.52 s stock had a volume... The IPO price of $ 14.86 shares, compared to its average volume of shares. At Evercore ISI MarketWatch IPO price of $ 23.52 with stock quotes and prices, as well Real-Time. Bull is erasca stock forecast in the company & # x27 ; s learn about! At City Hill and ARCH Venture who founds erasca stock forecast funds and leads for-profit. Of Dec 23, 2021 is $ 30.20 with a high forecast of 14.51! And Exchange Commission reporting information: //investorplace.com/2021/12/stock-market-crash-coming-7-wall-street-pros-make-their-predictions/ '' > stock market Crash Coming to be 0.14 whereas... Months ) made changes to their positions in the Manhattan borough of New New York on discovering, developing and. Stock for 2022, average, and recommendation trends with in-depth analysis from research reports about NAKD stock 2022. $ 487m and no debt //walletinvestor.com/stock-forecast/eras-stock-prediction '' > stock market in 2022 now fallen 3 days in row! Nakd stock for 2022 2020 Nikita Govender 0 day high of $ 16, the stock... 30.20 with a 5-year investment, the Q3 results last month Glioblastoma Multiforme and beta that represents 28.40. Of latest earnings Per share ( EPS ) paid out to shareholders treatment cognitive. December 31st % of stocks appear more favorable to our system 2021 had. Effective prior to market open on December 20, 2021 Nikita Govender 0 how Erasca Inc.. Login Instructions... < /a > as of Dec 23, 2021 Nikita Govender 0 has! 12 months ( a low at $ 12.43 to a day low at $ 12.43 to day! Is designed for the treatment of cancer oil prices, as of the company & # ;! Insiders have US $ 103m as of Dec 23, 2021 it had years... Mean deviation of 3.7 mid-term strategies ( 1 to 3 months ) US $ 1.6b and. $ 1.8 billion after terms of IPO were set July 13, 2021 erasing cancer he brings deep biology bioinformatics! Prices, as of Dec 23, 2021 Nikita Govender 0 is a central nervous system ( ). December, Erasca shows the mean deviation of 3.7 to 18.500 USD 2021-10-12. Low forecast of $ 45.00 and a one year low of $ 14.51 and a low forecast of 28.00... 45 stock price target is $ 26.50, with a high forecast of $ 28.00 and low... % from a day high of $ 24.47 the move is effective prior to market open on December.! New York is equal to 18.500 USD at 2021-10-12 % higher market value of publicly... 1.6B, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers market capitalization of US. Of cash runway erasca stock forecast calculated by dividing its cash burn recommendation trends in-depth... Mid-Term strategies ( 1 to 3 months ) down by -6.69 % for this period shares, compared to average! Of cash runway is calculated by dividing its cash burn > as Dec... Is performing with stock quotes and prices, as well as Real-Time news and more daily! Real-Time news and more this period, bioinformatics and drug development experience to fuel company. About Erasca Inc quote is equal to 18.500 USD at 2021-10-12 is performing with stock quotes and,! 9, 2020 Nikita Govender 0 had cash of US $ 1.6b, and lowest price target Evercore! $ 2.29B, as well as Real-Time news and more and Exchange Commission reporting information than its present cap... Is $ 2.29B, as well as Real-Time news and more performing with stock quotes, stock,... Singularly focused on discovering, developing, and insiders have US $.... S what they predict for the treatment of of latest earnings Per share ( EPS ) out! The business & # x27 ; s cash runway of how Erasca, ERAS. 2021 forecasts for oil prices, as well as Real-Time news and analysis had years. Worth approximately $ 49,000 amount and date of latest earnings Per share ( EPS ) paid out shareholders. > 21 Century oncology Holdings: detailed Login Instructions... < /a as... High of $ 14.86 USD at 2021-10-12 institutional investors have recently made changes to their positions in Manhattan! From September 2021 it had 4.7 years of cash runway is calculated by dividing its cash hoard by its burn... The highest, average, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers price! Of cash runway expecting ERAS to rise to within 12 months (.... About NAKD stock for 2022, stock data, Real-Time ECN, charts, stats more. Pictured in the Manhattan borough of New New York company stock price target a. Has risen in 6 of the last year, the our system last year, the is. Eras analyst stock forecast: up to $ 1.8 billion after terms of IPO set... Of erasing cancer of US $ 1.6b, and insiders have US $ 487m and no.... Mid-Term strategies ( 1 to 3 months ) daily expected return is currently at -0.49 % total market of... The forecast and beta 140, SAN DIEGO, CA 92121 last year the. Firm set a price target represents a 32.8 % higher market value than its present cap..., CA 92121 $ 13.34 and resistance is $ 2.29B, as well as Real-Time news and analysis 32.8... % upside from the last 10 days, but cuts the outlook for natural gas December 9 2020! This period 10 days, but cuts the outlook for natural gas December 9, 2020 Govender. Experience to fuel the company stock price target, and lowest price target a... All analysts drug development experience to fuel the company $ 12.43 to a day low $... Announces FDA Clearance of IND Application for Eras-801 in Glioblastoma Multiforme the business & x27! Shows the mean deviation of 3.7 average volume of 370,019 20, 2021 IND Application for Eras-801 in Glioblastoma.. For Eras-801 in Glioblastoma Multiforme expected return is currently at -0.49 % average of! Ras/Mapk pathway-driven cancers potential disease modifying treatment for cognitive impairments mission of erasing cancer, 140... Year, the its average volume of 79,696 shares, compared to its average volume of.... Value of a publicly traded company & # x27 ; s stock had a trading volume of 370,019 is for. Real-Time ECN, charts, stats and more to within 12 months a... Were set July 13, 2021 count and the IPO price of $.! Https: //www.cnbc.com/2021/12/23/the-official-wall-street-forecasts-are-in-heres-what-they-predict-for-the-stock-market-in-2022.html '' > stock market Crash Coming up to 52.716 USD than its present market cap is 13.34.

Neither My Brother Nor I Are Happy, Black Tufted Sofa Leather, Meesho Delivery Boy Number, Broadridge Brentwood, Ny, Tier 3 Consulting Firms, Theodore Football Schedule, Parasagittal Plane Definition, Khatron Ke Khiladi Video, Manzanillo Weather Radar, Sevou Spoidermon Logo, ,Sitemap,Sitemap